Karin van Leeuwen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karin van Leeuwen has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Dirk Roos
Amsterdam University Medical Center, Location AMC
2 shared publications - Martin de Boer
University of Amsterdam
2 shared publications - Arnon Broides
Soroka University Medical Center
1 shared publication - Begum Ozbek
Pediatric Immunology Laboratory, Department of Pediatrics, Hacettepe University Medical School, Ankara, Türkiye
1 shared publication - Cagman Tan
Department of Immunology, Institute of Child Health, Pediatric Basic Sciences, Hacettepe University, 06230 Ankara, Turkey
1 shared publication - Caroline S. B. Veen
Department of Hematology Erasmus MC, Erasmus University Medical Center Rotterdam The Netherlands
1 shared publication
Latest Publications
- Open Access
- 17 November 2026
- Published by Wiley in European Journal of Haematology
Bleeding Symptoms, Laboratory, and Molecular Genetic Results in Children With Platelet Disorders
Diagnosing and classifying platelet disorders (PD) is challenging in children. Therefore, we evaluated clinical, laboratory, and genetic data to improve current algorithms by performing a prospective observational cohort study in children (0–18 years) with a known genetic cause (proven PD), functional abnormalities, or thrombocytopenia without genetic cause (probable PD) or medical suspicion of PD (possible PD). We included 98 children (mean age 11.6 years, 55 females). PD was proven in 44, probable in 43, and possible in 11. Comorbidities were present in 43. Epistaxis, hematomas, menstrual, and perioperative bleeding were reported most frequently. Mean ISTH‐BAT bleeding score was 6.1 (SD 4.0, range 0–17), with higher scores in post‐pubertal females (mean 7.6) and lower scores in children with moderate thrombocytopenia (mean 4.8). Bleeding as a presenting symptom and older age were associated with higher bleeding scores. Treatment was indicated in 46 children. Most frequently, Light transmission aggregometry was abnormal for ADP, epinephrine, and thrombin. General laboratory parameters can hint to but not identify PD origin. Genetic testing led to novel diagnoses in 10 (23%) children with probable PD. We conclude that bleeding tendency is prominent but variable in children with PD. Routine laboratory tests are useful, but fail to diagnose the origin of PD. Therefore, genetic analysis is essential, especially as PD can be part of a syndrome leading to comorbidities or predispose for malignancies, both impacting counseling and surveillance. We propose a classification based on functional and genetic analysis leading to either an isolated or syndrome‐associated inherited PD or a functional PD. Trial Registration: ABR NL55101.078.16
- 17 November 2026
- Published by Wiley in European Journal of Haematology
Open AccessBleeding Symptoms, Laboratory, and Molecular Genetic Results in Children With Platelet Disorders
Diagnosing and classifying platelet disorders (PD) is challenging in children. Therefore, we evaluated clinical, laboratory, and genetic data to improve current algorithms by performing a prospective observational cohort study in children (0–18 years) with a known genetic cause (proven PD), functional abnormalities, or thrombocytopenia without genetic cause (probable PD) or medical suspicion of PD (possible PD). We included 98 children (mean age 11.6 years, 55 females). PD was proven in 44, probable in 43, and possible in 11. Comorbidities were present in 43. Epistaxis, hematomas, menstrual, and perioperative bleeding were reported most frequently. Mean ISTH‐BAT bleeding score was 6.1 (SD 4.0, range 0–17), with higher scores in post‐pubertal females (mean 7.6) and lower scores in children with moderate thrombocytopenia (mean 4.8). Bleeding as a presenting symptom and older age were associated with higher bleeding scores. Treatment was indicated in 46 children. Most frequently, Light transmission aggregometry was abnormal for ADP, epinephrine, and thrombin. General laboratory parameters can hint to but not identify PD origin. Genetic testing led to novel diagnoses in 10 (23%) children with probable PD. We conclude that bleeding tendency is prominent but variable in children with PD. Routine laboratory tests are useful, but fail to diagnose the origin of PD. Therefore, genetic analysis is essential, especially as PD can be part of a syndrome leading to comorbidities or predispose for malignancies, both impacting counseling and surveillance. We propose a classification based on functional and genetic analysis leading to either an isolated or syndrome‐associated inherited PD or a functional PD. Trial Registration: ABR NL55101.078.16
- Open Access
- 5 August 2021
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 206 (1) , 47-55
Clinical and laboratory findings in patients with leukocyte adhesion deficiency type I: A multicenter study in Turkey
Leukocyte adhesion deficiency type I is a rare primary immunodeficiency disorder characterized by mutations in the ITGB2 gene encoding CD18. We present clinical and immunological features of 15 patients with leukocyte adhesion deficiency type 1 (LAD-1). Targeted next-generation sequencing was performed with either a primary immunodeficiency gene panel comprising 266 genes or a small LAD-panel consisting of five genes for genetic analysis. To measure the expression level of integrins on the leukocyte surface, flow cytometry analysis was performed. The median age of the patients at diagnosis was 3 (1–48) months. Eleven (73%) of the 15 patients had a LAD-1 diagnosis in their first 6 months and 14 (93%) patients had consanguineous parents. Delayed separation of the umbilical cord was present in 80% (n = 12) of the patients in our cohort, whereas omphalitis was observed in 53% (n = 8) of the patients. Leukocytosis with neutrophil predominance was observed in 73% (n = 11) patients. Nine distinct variants in the ITGB2 gene in 13 of the 15 patients with LAD-1 were characterized, two of which (c.305_306delAA and c.779_786dup) are novel homozygous mutations of ITGB2. Four unrelated patients from Syria had a novel c.305_306delAA mutation that might be a founder effect for patients of Syrian origin. Four (27%) patients underwent hematopoietic stem cell transplantation. Two patients died because of HSCT complications and the other two are alive and well. Early differential diagnosis of the patients is critical in the management of the disease and genetic evaluation provides a basis for family studies and genetic counseling.
- 5 August 2021
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 206 (1) , 47-55
Open AccessClinical and laboratory findings in patients with leukocyte adhesion deficiency type I: A multicenter study in Turkey
Leukocyte adhesion deficiency type I is a rare primary immunodeficiency disorder characterized by mutations in the ITGB2 gene encoding CD18. We present clinical and immunological features of 15 patients with leukocyte adhesion deficiency type 1 (LAD-1). Targeted next-generation sequencing was performed with either a primary immunodeficiency gene panel comprising 266 genes or a small LAD-panel consisting of five genes for genetic analysis. To measure the expression level of integrins on the leukocyte surface, flow cytometry analysis was performed. The median age of the patients at diagnosis was 3 (1–48) months. Eleven (73%) of the 15 patients had a LAD-1 diagnosis in their first 6 months and 14 (93%) patients had consanguineous parents. Delayed separation of the umbilical cord was present in 80% (n = 12) of the patients in our cohort, whereas omphalitis was observed in 53% (n = 8) of the patients. Leukocytosis with neutrophil predominance was observed in 73% (n = 11) patients. Nine distinct variants in the ITGB2 gene in 13 of the 15 patients with LAD-1 were characterized, two of which (c.305_306delAA and c.779_786dup) are novel homozygous mutations of ITGB2. Four unrelated patients from Syria had a novel c.305_306delAA mutation that might be a founder effect for patients of Syrian origin. Four (27%) patients underwent hematopoietic stem cell transplantation. Two patients died because of HSCT complications and the other two are alive and well. Early differential diagnosis of the patients is critical in the management of the disease and genetic evaluation provides a basis for family studies and genetic counseling.
- 1 September 2018
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 6 (5) , 1775-1777.e1
Male X-chromosome mosaicism leading to carrier phenotype and inheritance of chronic granulomatous disease
- 1 September 2018
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 6 (5) , 1775-1777.e1
Male X-chromosome mosaicism leading to carrier phenotype and inheritance of chronic granulomatous disease
- 9 August 2018
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 38 (6) , 638-641
p47phox-/- Chronic Granulomatous Disease Patient with Incomplete Kawasaki Disease
- 9 August 2018
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 38 (6) , 638-641
p47phox-/- Chronic Granulomatous Disease Patient with Incomplete Kawasaki Disease
- 21 May 2011
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 31 (4) , 560-566
Two X-Linked Chronic Granulomatous Disease Patients with Unusual NADPH Oxidase Properties
Chronic granulomatous disease (CGD) is an immune deficiency syndrome caused by defects in the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, the enzyme that generates reactive oxygen species (ROS) in phagocytizing leukocytes. This study evaluates the NADPH oxidase capacity in two X-linked CGD patients with mutations in gp91phox that alter the regions in this membrane-bound NADPH oxidase component involved in docking of the cytosolic component p47phox. Hydrogen peroxide and superoxide generation, bactericidal activity, and NADPH oxidase protein expression by the patients’ neutrophils were measured, and genetic analysis was performed. We report two patients, each with a novel missense mutation in CYBB, the gene that encodes gp91phox. Surprisingly, neutrophils from these patients showed total absence of superoxide production, although they retained 13–30% of the hydrogen peroxide production capability. We speculate that this is due to direct electron transfer from flavin adenine dinucleotide (FAD) in gp91phox to oxygen, leading to inefficient hydrogen peroxide formation instead of efficient superoxide production. X-linked CGD patients with mutations that alter the gp91phox protein in regions involved in docking of the cytosolic NADPH oxidase component p47phox may have higher than expected hydrogen peroxide generation capability.
- 21 May 2011
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 31 (4) , 560-566
Two X-Linked Chronic Granulomatous Disease Patients with Unusual NADPH Oxidase Properties
Chronic granulomatous disease (CGD) is an immune deficiency syndrome caused by defects in the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, the enzyme that generates reactive oxygen species (ROS) in phagocytizing leukocytes. This study evaluates the NADPH oxidase capacity in two X-linked CGD patients with mutations in gp91phox that alter the regions in this membrane-bound NADPH oxidase component involved in docking of the cytosolic component p47phox. Hydrogen peroxide and superoxide generation, bactericidal activity, and NADPH oxidase protein expression by the patients’ neutrophils were measured, and genetic analysis was performed. We report two patients, each with a novel missense mutation in CYBB, the gene that encodes gp91phox. Surprisingly, neutrophils from these patients showed total absence of superoxide production, although they retained 13–30% of the hydrogen peroxide production capability. We speculate that this is due to direct electron transfer from flavin adenine dinucleotide (FAD) in gp91phox to oxygen, leading to inefficient hydrogen peroxide formation instead of efficient superoxide production. X-linked CGD patients with mutations that alter the gp91phox protein in regions involved in docking of the cytosolic NADPH oxidase component p47phox may have higher than expected hydrogen peroxide generation capability.